Log in to save to my catalogue

RANK-c attenuates aggressive properties of ER-negative breast cancer by inhibiting NF-κB activation...

RANK-c attenuates aggressive properties of ER-negative breast cancer by inhibiting NF-κB activation...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2047248017

RANK-c attenuates aggressive properties of ER-negative breast cancer by inhibiting NF-κB activation and EGFR signaling

About this item

Full title

RANK-c attenuates aggressive properties of ER-negative breast cancer by inhibiting NF-κB activation and EGFR signaling

Publisher

London: Nature Publishing Group UK

Journal title

Oncogene, 2018-09, Vol.37 (37), p.5101-5114

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

The RANK/RANKL axis emerges as a key regulator of breast cancer initiation, progression, and metastasis. RANK-c is a RANK receptor isoform produced through alternative splicing of the
TNFRSF11A
(
RANK
) gene and a dominant-negative regulator of RANK-induced nuclear factor-κB (NF-κB) activation. Here we report that
RANK-c
transcrip...

Alternative Titles

Full title

RANK-c attenuates aggressive properties of ER-negative breast cancer by inhibiting NF-κB activation and EGFR signaling

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2047248017

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2047248017

Other Identifiers

ISSN

0950-9232,1476-5594

E-ISSN

1476-5594

DOI

10.1038/s41388-018-0324-y

How to access this item